Related Experiment Video
Updated: May 16, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
Nanoparticle-Driven Advances in Antimicrobial Therapy: Strengthening Peptide Effectiveness
Lalit Kumar1,2, Vikas Aggarwal3, Vishnu Das4
1Department of Pharmaceutics, Shiva Institute of Pharmacy, Chandpur, Bilaspur, H.P. 174004, India.
Nanoparticle formulations enhance antimicrobial peptides (AMPs) delivery to combat multidrug-resistant pathogens. These systems improve AMP bioavailability and targeting, overcoming clinical limitations for infectious disease treatment.
Area of Science:
- Biotechnology
- Nanomedicine
- Infectious Diseases
Background:
- Antimicrobial peptides (AMPs) show potential against multidrug-resistant (MDR) pathogens.
- Clinical application of AMPs is limited by rapid clearance, poor tissue penetration, and degradation.
Purpose of the Study:
- To systematically analyze nanoparticle systems for antimicrobial peptide (AMP) administration.
- To evaluate advancements and obstacles in nanoparticle-mediated AMP delivery.
Main Methods:
- Systematic analysis of lipidic and polymeric nanoparticles for AMPs.
- Assessment of encapsulation efficiency, release kinetics, biocompatibility, and antibacterial activity.
- Evaluation of in vitro/in vivo data and patented technologies.
Main Results:
- Nanoparticles enhance AMP bioavailability, enabling targeted delivery and reducing toxicity against pathogens like ESKAPE.
- Stimuli-responsive systems and surface functionalization (PEGylation, ligand targeting) improve controlled release, stability, and specificity.
- Regulatory hurdles persist but are being addressed by global initiatives.
Conclusions:
- Nanoparticle-based AMP therapies offer a promising strategy for infectious diseases by overcoming delivery challenges.
- Further research should focus on scalable functionalization and regulatory pathways for clinical translation against MDR infections.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Effectiveness
Microbial Corrosion
Site-Targeted Drug Delivery Systems: Polymeric Carriers
